HIPERTENSÃO PORTAL (BAVENO) 2010
Portal hypertension is associated with the most severe complica- tions of cirrhosis, including ascites, hepatic encephalopathy, and bleeding from gastro-esophageal varices. Despite the progress achieved over the last decades, the 6-week mortality associated with variceal bleeding is still in the order of 10–20%. Awareness of the difficulty inherent to the evaluation of diagnostic tools and the design and conduct of good clinical trials for the treatment of portal hypertension has led to the organization, since 1986, of a ser- ies of consensus meetings. The first one was organized by Andrew Burroughs in Groningen, The Netherlands . After Groningen, other meetings followed, in Baveno in 1990 (Baveno I)  and in 1995 (Baveno II) [3,4], in Milan in 1992 , in Reston, USA, in 1996 , in Stresa in 2000 (Baveno III) [7,8], again in Baveno in 2005 (Baveno IV) [9,10] and in Atlanta in 2007 .